The effect of N,N,N'-tetramethylazoformamide (TMAF) on lysosomal stability in the presence and absence of anti-inflammatory agents.
D000135:Acid Phosphatase; D000255:Adenosine Triphosphate / Q000494:pharmacology; D000577:Amides / Q000494:pharmacology*; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D001241:Aspirin / Q000494:pharmacology; D001391:Azo Compounds / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D002738:Chloroquine / Q000494:pharmacology; D004336:Drug Antagonism; D005439:Flufenamic Acid / Q000494:pharmacology; D005559:Formamides / Q000037:antagonists & inhibitors / Q000494:pharmacology; D005966:Glucuronidase; D006596:Hexosaminidases; D006854:Hydrocortisone / Q000494:pharmacology; D066298:In Vitro Techniques; D007213:Indomethacin / Q000494:pharmacology; D008099:Liver / Q000187:drug effects; D008247:Lysosomes / Q000187:drug effects* / Q000201:enzymology; D008297:Male; D008528:Mefenamic Acid / Q000494:pharmacology; D008566:Membranes / Q000187:drug effects; D010653:Phenylbutazone / Q000494:pharmacology; D051381:Rats; D013429:Sulfatases
D000577:Amides; D000893:Anti-Inflammatory Agents; D001391:Azo Compounds; D005559:Formamides; D008528:Mefenamic Acid; D005439:Flufenamic Acid; D002738:Chloroquine; D000255:Adenosine Triphosphate; D000135:Acid Phosphatase; D013429:Sulfatases; D006596:Hexosaminidases; D005966:Glucuronidase; D010653:Phenylbutazone; D001241:Aspirin; D006854:Hydrocortisone; D007213:Indomethacin